Abstract
Keratinocyte growth factor (KGF), a potent growth factor for type II pneumocytes and Clara cells, has been shown to prevent the end-stage pulmonary fibrosis and mortality in a rat model of bleomycin-induced lung injury. In this study, protective effects of KGF were explored during the earlier course of bleomycin-induced lung injury by studying protein exudation in alveolar edema fluids, pulmonary expression of transforming growth factor-beta (TGFβ) and platelet-derived growth factor-BB (PDGF-BB), and changes in type II pneumocytes and Clara cells after i.t. (intratracheal) bleomycin injection following KGF- or saline-pretreatment in rats. Total protein in bronchoalveolar lavage (BAL) fluids after bleomycin injury from KGF-pretreated rats was significantly lower than the levels in saline-pretreated rats. TGFβ protein in BAL fluids which peaked at day 3 after i.t. bleomycin in saline-pretreated lungs was not significantly increased at any time points in KGF-pretreated rats. PDGF-BB protein in whole lung tissues of KGF-pretreated rats also remained near normal throughout the course after i.t. bleomycin, in contrast to the significant increase in saline-pretreated rats. Numbers of type II pneumocytes and Clara cells in KGF-pretreated lungs after a high dose of bleomycin were close to the normal in intact lungs. At the same dose of bleomycin injury, type II pneumocytes in saline-pretreated lungs were markedly decreased, while the number of Clara cells in these rats was relatively preserved as the pre-injury level. In conclusion, KGF prevents bleomycin-induced end-stage pulmonary injury and mortality probably at least partly by decreasing protein-rich pulmonary edema, protein expression of fibrogenic cytokines TGFβ and PDGF-BB, and type II cell loss during the course of lung injury.
Similar content being viewed by others
REFERENCES
Finch, P. W., S. S. Rubin, T. Miki, D. Ron, and S. A. Aaronson. 1989. Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science 245:752–755.
Panos, R. J., J. S. Rubin, S. A. Aaronson, and R. J. Mason. 1993. Keratinocyte growth factor and hepatocyte growth factor scatter factor after heparin-binding growth factor for alveolar type II cells in fibroblast-conditioned medium. J. Clin. Invest. 92:969–977.
Ulich, T. R., E. S. Yi, K. Longmuir, S. Yin, R. Blitz, C. F. Morris, R. M. Housley, and G. F. Pierce. 1994. Keratinocyte growth factor is a growth factor for type II pneumocytes in vivo. J. Clin. Invest. 93:1298–1236.
Yi, E. S., S. T. Williams, H. Lee, D. M. Malicki, E. M. Chin, S. Yin, J. Tarpley, and T. R. Ulich. 1996. Keratinocyte growth factor ameliorates radiation-and bleomycin-induced lung injury and mortality. Am. J. Pathol. 149:1963–1970.
Panos, R. J., P. M. Bak, W. S. Simonet, J. S. Rubin, and L. J. Smith. 1995. Intratracheal instillation of keratinocyte growth factor decreases hyperoxia-induced mortality in rats. J. Clin. Invest. 96:2026–2033.
Yano, T., R. R. Deterding, W. S. Simonet, J. M. Shannon, and R. J. Mason. 1996. Keratinocyte growth factor reduces lung damage due to acid instillation in rats. Am. J. Respir. Cell. Mol. Biol. 15:433–442.
Mason, C. M., B. P. H. Guery, W. R. Summer, and S. Nelson. 1996. Keratinocyte growth factor attenuates lung leak induced by alpha-naphthylthiourea in rats. Crit. Care Med. 24:925–931.
Rubin, J. S., H. Osada, P. W. Finch, W. G. Taylor, S. Rudikoff, and S. A. Aaronson. 1989. Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 86:802–806.
Ulich, T. R., L. R. Watson, S. Yin, K. Guo, P. Wang, H. Thang, and J. Del Castillo. 1991. The intracheal administration for endotoxin and cytokines. I. Characterization of LPS-induced IL-1 and TNF mRNA expression and the LPS-IL-1 TNF-induced inflammatory infiltrate. Am. J. Pathol. 138:1485–1496.
Yi, E. S., D. G. Remick, Y. Lim, W. Tang, J. H. Williams, K. Guo, C. E. Nadziejko, A. A. Bedoya, S. Yin, and T. R. Ulich. 1996. Intratracheal injection of endotoxin: X, Dexamethasone downregulates neutrophil emigration and cytokine expression in vivo. Inflammation 20:165–175.
Danielpour, D., K. Y. Kim, L. L. Dart, S. Satanabe, A. B. Roberts, and M. B. Sporn. 1989. Sandwich enzyme-linked immunosabsorbent assays (SELISAs) quantitate and distinguish two forms of transforming growth factor-beta (TGFβ1 and TGFβ2) in complex biological fluids. Growth Factors 2:61–71.
Masliah, E., M. Mallory, M. Alford, R. Deteresa, and T. Saitoh. 1995. PDGF is associated with neuronal and glial alterations of Alzheimer's disease. Neurobiology of Aging 16:549–556.
Harrison, J. H., D. G. Jr., Hoyt, and J. S. Lazo. 1989. Acute pulmonary toxicity of bleomycin: DNA scission and matrix protein mRNA levels in bleomycin-sensitive and-resistant strain of mice. Mol. Pharmacol. 36:231–238.
Guery, B. P. H., C. M. Mason, E. P. Dobard, G. Beaucaire, W. R. Summer, and S. Nelson. 1997. Keratinocyte growth factor increases transalveolar sodium reabsorption in normal and injured rat lungs. Am. J. Respir. Crit. Care Med. 155:1777–1784.
Scneeberger, E. E., and K. M. McCarthy. 1986. Cytochemical localization for the Na, K-ATPase in rat type II pneumocytes. J. Appl. Physiol. 60:1584–1589.
Waters, C. M., U. Savla, and R. J. Panos. 1997. Keratinocyte growth factor protects airway epithelial cells from a hydrogen peroxide-induced permeability increase. Am. J. Crit. Care Med. 155:A173.
Lestrud, S. O., R. J. Panos, and P. H. S. Sporn. 1997. Keratinocyte growth factor upregulates leukotriene C4 synthesis in cultured rat alveolar type II cells. Am. J. Crit. Care Med. 155:A790.
Panos, R. J., and P. M. Pak. 1997. Keratinocyte growth factor increases whole lung SP-A, B, and C transcript levels. Am. J. Crit. Care Med. 155:A642.
Phan, S. H., and S. L. Kunkel. 1992. Lung cytokine production in bleomycin-induced pulmonary fibrosis. Exp. Lung Research 18:29–43.
Kelley, J. 1993. In Transforming growth factor beta. In Cytokines of the Lung, 1st ed., J. Kelley, editor. Marcel Dekker, New York, 101–137.
Raghow, R., P. Irish, and A. H. Kang. 1989. Coordinate regulation of TGF-beta gene expression and cell proliferation in hamster lungs undergoing bleomycin-induced pulmonary fibrosis. J. Clin. Invest. 84:1836–1842.
Breen, E., S. Shull, S. Burne, M. Absher, and J. Kelly. 1992. Bleomycin regulation of TGF-beta mRNA in rat lung fibroblasts. Am. J. Res. Cell Mol. Biol. 6:146–152.
Giri, S. N., D. M. Hyde, and M. A. Hollinger. 1993. Effect of antibody to TGF-beta on bleomycin induced accumulation of lung collagen in mice. Thorax 8:959–966.
Khalil, N., R. N. O'Connor, K. C. Flanders, S. Shing, and C. I. Whitman. 1994. Regulation of type II alveolar epithelial cell proliferation by TGF-beta during bleomycin-induced lung injury in rats. Am. J. Physiol. 267:L498–507.
Westergren-Thprsson, G., J. Hernnas, B. Sarnstrand, A. Oldberg, D. Heinegard, and A. Malmstrom. 1993. Altered expression of small proteoglycans, collagen, and TGF-beta 1 in developing bleomycin-induced fibrosis in rats. J. Clin. Invest. 92:632–637.
Yi, E. S., A. Bedoya, H. Lee, E. Chin, W. Saunders, S. J. Kim, D. Danielpour, D. G. Remick, S. Yin, and T. R. Ulich. 1996. Radiation-induced lung injury in vivo: Expression of TGF-beta precedes fibrosis. Infl. 20:339–351.
Yoshida, M., J. Sakuma, S. Hayashi, K. Abe, I. Saito, S. Harada, M. Sakatani, S. Yamamoto, N. Matsumoto, U. Kaneda, and T. Kishimoto. 1995. A histologically distinctive interstitial pneumonia induced by overexpression of the IL-6, TGF-beta, and PDGF-B gene. Proc. Natl. Acad. Sci. U.S.A. 92:9570–9574.
Kovacs, E. J., and J. Kelley. 1985. Secretion of macrophage-derived growth factor during acute lung injury by bleomycin. J. Leukocyte Biol. 37:1–14.
Yi, E. S., H. Lee, S. Yin, P. Piguet, I. Sarosi, S. Kaufmann, J. Tarpley, N. S. Wang, and T. R. Ulich. 1996. PDGF causes pulmonary cell proliferation and collagen deposition in vivo. Am. J. Pathol. 149:539–548.
Witschi, H. 1991. Role of the epithelium in lung repair: patterns of epithelial repair and pulmonary fibrosis. Chest 99:22S–25S.
Bedrossian, C. W. M., M. A. Luna, B. Mackay, and B. Lightiger. 1973. Ultrastructure of pulmonary bleomycin toxicity. Cancer 32:44–51.
Terzaghi, M., P. Nettesheim, and M. L. Williams. 1978. Repopulation of denuded tracheal grafts with normal, preneoplastic and neoplastic epithelial cell populations. Cancer Res. 38:4546–4553.
Hagimoto, N., K. Kuwano, Y. Nomoto, R. Kunitake, and N. Hara. 1997. Apoptosis and expression of Fas/Fas ligand mRNA in bleomycin-induced pulmonary fibrosis in mice. Am. J. Respir. Cell Mol. Biol. 16:91–101.
Singh, G., S. L. Katyal, W. E. Brown, A. L. Kennedy, U. Singh, and M. L. Whong Chong. 1990. Clara cell 10 kDa protein (CC-10): comparison of structure and function with uteroglobin. Biochim. Biophys. Acta 1039:348–355.
Hashimoto, S., K. Nakagawa, and K. Sueishi. 1996. Monkey Clara cell 10 kDa protein. Am. J. Respir. Cell. Mol. Biol. 15:361–366.
Lesur, O., A. Bernard, K. Arsalane, R. Lauwerys, R. Begin, A. Antin, and D. Lane. 1995. Clara cell protein (CC-16) induces a phospholipase A2-mediated inhibition of fibroblast migration in vitro. Am. J. Respir. Crit. Care Med. 152:290–297.
Johnston, C. J., G. W. Mango, J. N. Finkelstein, and B. R. Stripp. 1997. Altered pulmonary response to hyperoxia in Clara cell secretory protein deficient mice. Am. J. Respir. Cell. Mol. Biol. 17:147–155.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yi, E.S., Salgado, M., Williams, S. et al. Keratinocyte Growth Factor Decreases Pulmonary Edema, Transforming Growth Factor-Beta and Platelet-Derived Growth Factor-BB Expression, and Alveolar Type II Cell Loss in Bleomycin-Induced Lung Injury. Inflammation 22, 315–325 (1998). https://doi.org/10.1023/A:1022304317111
Issue Date:
DOI: https://doi.org/10.1023/A:1022304317111